SCHEMBL7604269

SCHEMBL7604269

COC(=O)N(c1ccccc1)c1cnc(C2CCCCN2C(=O)OC(C)(C)C)cc1O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PRMT5 O14744 4/20 0.37
WDR77 Q9BQA1 4/20 0.37
HSD11B1 P28845 1/20 0.36
USP30 Q70CQ3 3/20 0.36
POLB P06746 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
WNT3 P56703 2/20 0.35
SFRP1 Q8N474 2/20 0.35
UCHL1 P09936 1/20 0.35
AADAT Q8N5Z0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727851 0.76 UCHL1 (0.41) TSHRMEN1ALDH1A1LMNAKMT2A
SCHEMBL5730247 0.74 GFER (0.45) TSHRMEN1ALDH1A1KMT2AL3MBTL1
SCHEMBL5727924 0.73 HSD11B1 (0.41) MEN1ALDH1A1LMNAKMT2AL3MBTL1
SCHEMBL30308800 0.71 TSHR (0.46) TSHRMEN1ALDH1A1LMNAKMT2A
SCHEMBL29491244 0.71 PRMT5 (0.55) TSHRMEN1ALDH1A1LMNAKMT2A
SCHEMBL28814072 0.71 PRMT5 (0.55) TSHRMEN1ALDH1A1LMNAKMT2A
SCHEMBL29081662 0.70 LMNA (0.46) TSHRMEN1ALDH1A1LMNAKMT2A
SCHEMBL29331534 0.69 ALDH1A1 (0.41) TSHRMEN1ALDH1A1LMNAKMT2A
SCHEMBL24365782 0.69 RIPK1 (0.63) TSHRMEN1ALDH1A1LMNAKMT2A
SCHEMBL7469150 0.69 RIPK1 (0.63) TSHRMEN1ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020103377-A1 Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103377-A1 Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials OXA1L, RPS27L, RPS27 TSHR 3674/4885MEN1 3697/4885ALDH1A1 550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.